FreeGulliver LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,500
Closed -$1.24M 91
2025
Q1
$1.24M Sell
1,500
-15,900
-91% -$13.2M 0.61% 23
2024
Q4
$13.4M Buy
+17,400
New +$14.4M 6.4% 3

Other funds holding LLY

FreeGulliver LLC's LLY Position: Q1 2026 in Review

FreeGulliver LLC increased its Eli Lilly (LLY) stake by 4.1% in Q1 2026, buying an estimated $25.3K and bringing the position to 642 shares worth $590K. The position accounts for 0.25% of the portfolio, ranked #47.

FreeGulliver LLC first reported a position in LLY in Q3 2024 and has held it in 6 quarters since. The position peaked at $663K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • FreeGulliver LLC held 642 shares of Eli Lilly worth $590K as of Q1 2026.
  • FreeGulliver LLC bought 25 Eli Lilly shares in Q1 2026, an estimated $25.3K.
  • Eli Lilly made up 0.25% of FreeGulliver LLC's portfolio in Q1 2026, its #47 holding.
  • FreeGulliver LLC first reported a position in Eli Lilly in Q3 2024 and has held it in 6 quarters since.
  • FreeGulliver LLC's Eli Lilly position peaked at $663K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on FreeGulliver LLC's 13F filing for Q1 2026, filed 15 May 2026.